
Lilly's Retatrutride Lawsuits: The First Pre-Approval Black Market in Obesity Drug History
Eli Lilly filed six lawsuits, five in Texas, against sellers of unapproved retatrutride, a triple-ag...
Read more →
Eli Lilly filed six lawsuits, five in Texas, against sellers of unapproved retatrutride, a triple-ag...
Read more →
The CDC's August 13 tally of 2,566 confirmed U.S. measles cases in 2026 surpasses last year's total ...
Read more →
UCLA's MethylScan, published in PNAS, reads cell-free DNA methylation to detect multiple cancers and...
Read more →
University of Miami researchers identified an abnormal UNC13A RNA signature, tied to TDP-43 dysfunct...
Read more →
The FDA's August 13 accelerated approval of iberdomide (Zenbexus) with daratumumab and dexamethasone...
Read more →
Washington has pulled healthcare's pricing, research and immunization levers in a single fortnight, ...
Read more →
HHS Secretary RFK Jr.'s USPSTF overhaul, new Medicaid work requirements, and sweeping PBM reforms ar...
Read more →
Over the past quarter, five biological arbitrage pipelines have opened in sports and entertainment: ...
Read more →
The 2026 awards season is executing a massive structural reconvergence, anchoring the VMAs, Emmys, a...
Read more →
LVMH is exploring the sale of its 50% stake in Rihanna's Fenty Beauty to Jay-Z's MarcyPen Capital Pa...
Read more →Three unrelated policy and capital events — the first FDA-approved mRNA flu vaccine, the Medicare ...
Read more →An in-depth impact analysis of the 2026 awards season, examining the macroeconomic fallout of the Os...
Read more →